Inflammatory markers and androstenedione modify the effect of serum testosterone on obesity among men: Findings from a Chinese population.
Changsheng HuanMian WangYu SongZexin JiaDandan WeiLulu WangQingqing XuJuan WangMengzhen ZhaoJintian GengJiayu ShiCuicui MaZhenxing MaoChongjian WangWenqian HuoPublished in: Andrology (2023)
Inflammatory markers and androstenedione were first found to have modifying effects on the association of testosterone with obesity. Higher levels of testosterone and androstenedione could reduce the inflammation level and risk of obesity, indicating their potential roles in the prevention and treatment of chronic diseases.